It has become clear in recent years that one should not consider HDLs as a homogenous entity when studying their functions. It is now indeed recognized and well documented that the HDL pool in the blood is made of a variety of HDL particles that differ in terms of structure, composition, and signaling molecules they carry. More than 80 proteins and peptides and more than 200 lipid species have been detected in HDLs [1] . However, a single HDL particle only carries a distinct subset of these molecules. For example, less than 10% of HDL particles carry the bioactive sphingosine-1-phosphate (S1P) lipid [1] . The diversity in the composition of HDLs can potentially explain the variety of their functions ranging from reverse cholesterol transport to antioxidative, anti-inflammatory, and cytoprotective activities (recently reviewed in [2] and [3] ).
HDL particles are more plastic and dynamic than initially thought as recently highlighted by O'Neill et al. [4] in their study on patients with periodontitis. This human model is of interest because it involves a low-grade inflammation systemic status developing from a local inflammation site (the teeth). The etiology of the inflammation is therefore somehow simpler than what is seen in more complex diseases such as diabetes or the metabolic syndrome. Moreover, this model allows researchers to study the impact of low-grade inflammation in individuals that serve as their own controls after periodontitis is treated. In this study, periodontitis led to disturbed HDL vascular functions such as diminished paraoxonase activity and reduced ability to induce nitric oxide production by endothelial cells. Intriguingly, the cholesterol extraction capacity of HDLs was not affected by periodontitis, suggesting that only a subset of HDL functions and activities are affected by lowgrade inflammation. Although this study is in line with others (see [5] [6] [7] for recent publications) that showed disease-induced alterations in HDL functions, its salient point is that low-grade inflammation-associated perturbations in HDL functions and composition could be fully normalized with the resolution of the disease. Hence, HDLs are very plastic particles whose functions are dynamically regulated by transition between healthy and disease states.
Two recent studies by the group of Timothy
&& ] demonstrated the importance of the structure and molecules that carry S1P in the responses elicited by this lipid in cells and tissues.
In the blood, about two-thirds of the S1P molecules are bound to apolipoprotein M (ApoM), an apolipoprotein present in about 10% of HDL particles [1] , whereas the remaining molecules are associated with albumin. HDL-S1P was shown to bind to the S1P 1 receptor on endothelial cells and activate a protective anti-inflammatory and antiatherosclerotic signal in the vasculature [8 & ] . Surprisingly, S1P bound to albumin did not generate these protective responses, despite being able to activate S1P 1 . The resolution of this conundrum came through detailed investigation of the signaling pathway activated by albumin-S1P and HDL-S1P: at similar S1P concentrations (1-2 mmol/l), both albumin-S1P and HDL-S1P stimulated the mitogen-activated protein kinase pathway efficiently but albumin-S1P triggered greater G i activation and receptor endocytosis, whereas only HDL-S1P induced the formation of a S1P 1 -b-arrestin-2 complex that attenuated proinflammatory cytokine signaling. In a different experimental system, the same group reported that HDL-S1P, but not albumin-S1P, kept in check lymphopoiesis, and in a mouse model of autoimmune encephalitis, restrained the development of self-reacting lymphocytes [9 && ]. These two studies open the possibility that ApoM-containing HDL particles 'present' S1P to S1P receptors in a manner different than when S1P is carried by other carriers. As suggested by the authors, HDL-S1P may in fact act as a biased agonist for S1P receptors. How Galvani S, Sanson M, Blaho VA, et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal 2015; 8:ra79. In this article, the role of the S1P receptor 1 in vascular disease was investigated. The expression of S1P receptor 1 on the plasma membrane of aortic endothelial cells was found to be inversely correlated with inflammatory adhesion molecule abundance. This is an indication that S1P signaling in the vasculature dampens inflammation. Interestingly, the vasculature protective function of S1P occurred when this ligand was bound to ApoM-positive HDL particles but not when it was bound to albumin. Hence, an intriguing finding of this article was that S1P signaling is modulated by its carrier. This study extends some of the notions highlighted in [8 & ] and, importantly, characterizes a new function for HDLs. The authors discovered that S1P, when bound to ApoM-positive HDLs, but not when bound to albumin, acts as a negative regulator of lymphocytes differentiation and proliferation. In the absence of S1P signaling in bone marrow progenitors, lymphopoiesis was augmented and this worsened neuroinflammation in a model of experimental autoimmune encephalomyelitis. Apparently, therefore, S1P 1 receptor activation by HDL-S1P in lymphocyte progenitors participates in the maintenance of an adequately sized lymphocyte compartment. . Apolipoprotein A1, one of the major protein present in HDL particles, has long been recognized as having anti-inflammatory and antiapoptotic properties. This study shows for the first time that the type of phospholipid used to reconstitute HDL particles from ApoA1 has significant influence on the reconstituted HDL (rHDL)-mediated protective effects. Hence, the phospholipids present in the ''membrane'' of HDLs particles are not just fulfilling a structural role in HDLs but also actively participate in the biological functions of the particles.
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